The firm is a globally diversified healthcare venture capital firm headquartered in Asia, with a strong presence across North America, Europe, and other international markets. The firm maintains a globally balanced portfolio and partners with a broad network of institutional, clinical, and commercial stakeholders. In addition to capital, the firm provides hands-on support in strategy, cross-border expansion, manufacturing partnerships, and distribution, helping portfolio companies scale internationally and navigate complex healthcare ecosystems.
The firm invests across early- to growth-stage opportunities, with a focus on medical devices, digital health, healthcare services, and AI-enabled solutions. Key areas of interest include oncology and radiotherapy, ophthalmology, brain health and neuromodulation, cardiovascular diseases, women’s and children’s health, and chronic disease management such as diabetes. The firm prioritizes technologies that address meaningful clinical needs and have the potential for broad global impact.
From a company and management team perspective, the firm seeks to partner with mission-driven founders developing innovative healthcare solutions. The firm does not impose strict requirements on management teams but values integrity, strong execution capability, and the ability to scale across international markets.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment